Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-013739
Filing Date
2017-08-04
Accepted
2017-08-04 07:03:31
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbm20170630_10q.htm 10-Q 735285
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13131
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13364
4 EXHIBIT 32 ex32.htm EX-32 8292
  Complete submission text file 0001437749-17-013739.txt   4339612

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbm-20170630.xml EX-101.INS 953988
6 XBRL TAXONOMY EXTENSION SCHEMA cbm-20170630.xsd EX-101.SCH 42912
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbm-20170630_cal.xml EX-101.CAL 48143
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbm-20170630_def.xml EX-101.DEF 302239
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbm-20170630_lab.xml EX-101.LAB 275174
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbm-20170630_pre.xml EX-101.PRE 325240
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

EIN.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10638 | Film No.: 171006875
SIC: 2834 Pharmaceutical Preparations